Searched for
BIOTECH IPO INDIA
Q-Line Biotec shares to list today. Check GMP ahead of debutQ-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...- IPO calendar: 3 companies set to launch public offers this week; check detailsThis comes as markets continue to witness sharp downswings and muted recoveries, with oil prices remaining elevated amid the seesaw politic...
- Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...
- Flipkart puts IPO on ice; Rapido's $240 million raiseFlipkart has hit pause on its IPO in a jittery market. This and more in today's ETtech Top 5.
- Deeptech bets heat up; Paytm, PB Fintech, Meesho earningsHappy Thursday! VCs are doubling down on India’s deeptech, with early-stage bets leading the charge. This and more in today’s ETtech Mornin...
- Early-stage tech draws VC interest across aviation, biotech, precision manufacturingInvestors are prioritising smaller, early-stage deals in deeptech sectors like AI, healthcare, and precision manufacturing, shying away fro...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Anthem BioSciences shares jump 4% as Citi initiates with Buy rating. Check target, upside potentialShares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Ana...
- September likely to witness a flood of locked-in sharesEnding of the lock-in period does not necessarily mean investors who received shares in the pre-IPO sale will offload their entire holdings...
- Concord Biotech shares list at a healthy premium. What should investors do?Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in ...
- Concord Biotech IPO share allotment likely today. Here's how you can check statusOn the allotment date, investors get to know about the number of shares allotted to them as against the bids made. They can check the allot...
- Concord Biotech IPO to open on August 4. Here are 10 things to know about the offerThe initial public offering (IPO) of Concord Biotech will open for subscription on August 4. The issue closes on August 8. The company's sh...
- Jhunjhunwala-backed Concord Biotech sets IPO price band at Rs 705-741According to the draft papers, Concord Biotech's IPO is entirely an offer for sale of (OFS) of 2,09,25,652 equity shares by Helix Investmen...
- Three companies file papers to raise Rs 7,500 cr as buzz returns to IPO marketSo far in 2022, about 63 companies have filed draft papers with Sebi, while 17 companies, including LIC, have raised about ₹41,140 crore fr...
- Devyani lists at 56% premium to IPO price, others witness muted debutsShares of Devyani International listed at a premium of more than 56% to their offer price while the other three companies that debuted alon...
- Rossari Biotech plans to launch Rs 500-crore IPO next weekThis would be the first company to brave the current volatile markets.
- Rossari Biotech defers IPO press conference amid market routThe company was likely to launch its IPO on March 18.
- Rossari Biotech files papers for Rs 700-crore IPOThe issue will comprise a fresh issue of Rs 150 crore and OFS of up to 1.05 crore shares.
- Indian biotech industry at critical juncture, global biotech stabilizes: ReportIndian biotech industry at critical junction, while global biotech industry showed a 2nd straight yr of increasingly stable financial perfo...
- Biotechnology sector to have more M&A activity due to fund crunch: ReportPaucity of funding for the Indian biotechnology sector for expanding its operations forces it to look towards mergers and acquisitions, acc...
Load More
